Current position: Long CRON.US

Cronos Group (CRON.US). Marijuana stock.

Technical comment:

The company’s shares broke the short-term downward wedge, holding more than 200 – the average average and a break and closing above 50 – the average. Price managed to break through successfully and level 23.6 at Fibonacci. Shares remain in long-term upward trend. CCI and RSI confirm the purchase signal.

Fundamental comment:

The company released better-than-expected reports. Merrill Lynch has updated its expectations for the company with a buy-in rating and a $ 27 target. The company is also highly oriented to the cannabis market and the development of such products. The niche is extremely potential and undeveloped.

 Trader Martin Nikolov

Read more:
If you think, we can improve that section,
please comment. Your oppinion is imortant for us.
WARNING: Any news, opinions, research, data or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. Varchev Finance Ltd. expressly disclaims any liability for any lost principal or profits which may arise directly or indirectly from the use of or reliance on such information. Varchev Finance Ltd. may provide information, quotes, references and links to or from other sites and blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the sites, blogs or other sources of information.
Varchev Finance